The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

Insights from manufacturers that have already transformed their operations with AI indicate a preference for moving AI inference to the edge using vector stores and ...

Pluristyx, a leading provider of innovative, unmodified, and gene-edited induced pluripotent stem cell (iPSC) lines, submitted a Type II Drug Master File (DMF) to the U.S. Food and Drug Administration ...

Ladies and gentlemen, welcome to the Cognizant Technology Solutions' Fourth Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the ...

A recent IMF study highlights China’s unparalleled global economic influence, with its GDP fluctuations generating ...

The organizational strength of Canada’s mining and smelting sector is coming to bear on the new White House administration’s ...

AdAlta (ASX:1AD) is bringing cellular immunotherapy products from Asian to western markets to drive value creation.

Viralgen and the CTNNB1 Foundation have come together to manufacture an investigational gene therapy designed to treat CTNNB1 Syndrome, a rare genetic disorder that affects motor and cognitive ...

Advanced Therapeutics Pharmaceutical Outsourcing IndustryFuture Market Insights (FMI), a leading provider of industry analysis and market research, has unveiled its latest report highlighting the ...

Financial GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs 05.02.2025 / 15:06 CET/CEST The issuer is solely responsible for the content of this ...